"This looks and feels like 2000," says investing legend

Our senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says it could be the worst U.S. financial crisis in 200 years. Before the next trading session begins, I highly recommend you review Dan's action plan to secure your gains, even if the market falls from here.

Click here to see how Dan says you could profit from the American "Mega Bubble" of 2025.

APRE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.80%

Insider Buying (Last 12 Months): $237,048.00

Insider Selling (Last 12 Months): $29,595.96

Aprea Therapeutics Insider Trading History Chart

Aprea Therapeutics Share Price & Price History

^$3.22

▲ +0.02 (0.63%)

As of 12/16/2024 12:20 PM ET

Days: 30 | 90 | 365

Wall Street Icon: “You must get on the right side of this thing”

From InvestorPlace | Ad

I created one of the first quantitative analysis-based stock picking systems long before "quants" became a thing on Wall Street… leading Forbes to call me "King of the Quants." I'm writing to you today because my system has recently uncovered a market phenomenon I haven't seen in 30 years.

This market shakeup is going to be much more intense.

Aprea Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/23/2024	Oren Gilad	CEO	Buy	500	$3.92	$1,960.00	333,395
10/18/2024	Marc Duey	Director	Sell	6,462	$4.58	$29,595.96	233,651
10/16/2024	Marc Duey	Director	Buy	30,000	$4.39	$131,700.00	240,113
10/14/2024	Marc Duey	Director	Buy	190	$2.58	$490.20	210,113
10/14/2024	Oren Gilad	CEO	Buy	1,000	$2.59	$2,590.00	332,645
10/11/2024	Bernd R Seizinger	Director	Buy	10,000	$2.68	$26,800.00	44,730
10/10/2024	John P Hamill	CFO	Buy	450	$2.61	$1,174.50	19,318
10/10/2024	Oren Gilad	CEO	Buy	150	$2.54	$381.00	331,645
3/13/2024	Bernd R Seizinger	Director	Buy	6,860	$7.29	$50,009.40	33,685
3/13/2024	John P Hamill	CFO	Buy	1,010	$7.29	$7,362.90	15,503
3/13/2024	Oren Gilad	CEO	Buy	2,000	$7.29	$14,580.00	324,770
6/6/2023	Bernd R Seizinger	Director	Buy	4,068	$3.63	$14,766.84	20,296
2/28/2022	Eyal C. Attar	SVP	Sell	1,800	$34.60	$62,280.00

Amazon coin set to soar 25X – starting December 16th?

From True Market Insiders | Ad

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024

>3-Cent Amazon Coin<

SEC Filings (Institutional Ownership Changes) for Aprea Therapeutics (NASDAQ:APRE)

34.19% of Aprea Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aprea Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/21/2024	Stonepine Capital Management LLC	137,174	$0.56M	0.5%	N/A	2.526%
8/9/2024	Dimensional Fund Advisors LP	11,071	$45K	0.0%	N/A	0.204%
5/15/2023	AIGH Capital Management LLC	345,000	$1.53M	0.6%	N/A	9.244%
5/15/2023	Sio Capital Management LLC	280,000	$1.24M	0.6%	N/A	7.503%
5/12/2022	Gyon Technologies Capital Management LP	20,570	$38K	0.0%	N/A	0.094%
5/12/2022	Magnus Financial Group LLC	14,856	$28K	0.0%	-56.3%	0.068%
2/15/2022	Kennedy Capital Management Inc.	336,730	$0.97M	0.0%	-1.7%	1.569%
2/14/2022	PDT Partners LLC	142,600	$0.41M	0.0%	+62.5%	0.664%
2/10/2022	Magnus Financial Group LLC	33,981	$98K	0.0%	N/A	0.158%
11/16/2021	Verition Fund Management LLC	20,101	$0.10M	0.0%	N/A	0.094%
11/12/2021	Geode Capital Management LLC	198,339	$1.01M	0.0%	+89.9%	0.936%
11/10/2021	Goldman Sachs Group Inc.	144,758	$0.74M	0.0%	+131.4%	0.683%
11/9/2021	BlackRock Inc.	354,275	$1.81M	0.0%	-0.9%	1.672%
9/17/2021	Virtu Financial LLC	41,142	$0.20M	0.0%	+292.9%	0.194%
8/17/2021	Walleye Capital LLC	98,931	$0.48M	0.0%	-16.5%	0.467%
8/17/2021	Walleye Trading LLC	27,455	$0.13M	0.0%	-33.4%	0.130%
8/16/2021	PDT Partners LLC	124,234	$0.61M	0.0%	N/A	0.586%
8/16/2021	Morgan Stanley	1,019,776	$4.98M	0.0%	+2.2%	4.813%
8/16/2021	Kennedy Capital Management Inc.	353,926	$1.73M	0.0%	+575.2%	1.670%
8/16/2021	Charles Schwab Investment Management Inc.	50,366	$0.25M	0.0%	-26.5%	0.238%
8/16/2021	State Street Corp	40,832	$0.20M	0.0%	-67.2%	0.193%
8/16/2021	Goldman Sachs Group Inc.	62,546	$0.31M	0.0%	-14.4%	0.295%
8/13/2021	Northern Trust Corp	32,530	$0.16M	0.0%	-69.2%	0.154%
8/13/2021	Geode Capital Management LLC	104,447	$0.51M	0.0%	-35.2%	0.493%
8/13/2021	Vanguard Group Inc.	707,422	$3.45M	0.0%	-6.0%	3.339%
8/12/2021	SG Americas Securities LLC	598,395	$2.92M	0.0%	-8.8%	2.824%
8/12/2021	JPMorgan Chase & Co.	60,315	$0.29M	0.0%	+264.4%	0.285%
8/12/2021	Ergoteles LLC	18,570	$91K	0.0%	N/A	0.088%
8/11/2021	Great Lakes Advisors LLC	17,895	$87K	0.0%	N/A	0.084%
8/11/2021	Bank of New York Mellon Corp	16,843	$83K	0.0%	-64.8%	0.079%
5/19/2021	Virtu Financial LLC	10,471	$53K	0.0%	-56.4%	0.049%
5/18/2021	Voloridge Investment Management LLC	304,198	$1.55M	0.0%	N/A	1.436%
5/18/2021	Morgan Stanley	998,127	$5.09M	0.0%	+111.0%	4.711%
5/18/2021	Redmile Group LLC	694,918	$3.54M	0.0%	-45.2%	3.280%
5/17/2021	Royal Bank of Canada	15,173	$76K	0.0%	+76.5%	0.072%
5/17/2021	Walleye Trading LLC	41,254	$0.21M	0.0%	+7.4%	0.195%
5/17/2021	Walleye Capital LLC	118,476	$0.60M	0.0%	+17.5%	0.559%
5/17/2021	HRT Financial LP	73,587	$0.38M	0.0%	N/A	0.347%
5/17/2021	Nuveen Asset Management LLC	17,565	$90K	0.0%	-48.7%	0.083%
5/17/2021	5AM Venture Management LLC	619,157	$3.16M	0.6%	-55.1%	2.922%
5/17/2021	Goldman Sachs Group Inc.	73,107	$0.37M	0.0%	N/A	0.345%
5/14/2021	Kennedy Capital Management Inc.	52,415	$0.27M	0.0%	N/A	0.247%
5/14/2021	FIL Ltd	83,191	$0.42M	0.0%	+17,267.6%	0.393%
5/14/2021	UBS Asset Management Americas Inc.	22,700	$0.12M	0.0%	N/A	0.107%
5/13/2021	Trexquant Investment LP	25,361	$0.13M	0.0%	N/A	0.120%
5/13/2021	SG Americas Securities LLC	655,888	$3.35M	0.0%	+2,725.9%	3.096%
5/13/2021	Bank of New York Mellon Corp	47,783	$0.24M	0.0%	+57.5%	0.226%
5/12/2021	Northern Trust Corp	105,719	$0.54M	0.0%	-6.8%	0.499%
5/12/2021	Geode Capital Management LLC	161,147	$0.82M	0.0%	+9.1%	0.761%
5/12/2021	JPMorgan Chase & Co.	16,550	$85K	0.0%	+380.3%	0.078%
5/7/2021	BlackRock Inc.	810,852	$4.14M	0.0%	-2.1%	3.827%
5/7/2021	Versant Venture Management LLC	1,259,662	$6.42M	1.3%	-11.7%	5.945%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	8,254	$42K	0.0%	N/A	0.039%
4/16/2021	NEXT Financial Group Inc	11,765	$60K	0.0%	N/A	0.056%
3/12/2021	DekaBank Deutsche Girozentrale	7,000	$35K	0.0%	N/A	0.033%
2/24/2021	Virtu Financial LLC	24,029	$0.12M	0.0%	N/A	0.113%
2/17/2021	Jane Street Group LLC	11,856	$58K	0.0%	N/A	0.056%
2/16/2021	Walleye Trading LLC	38,400	$0.19M	0.0%	N/A	0.181%
2/16/2021	Walleye Capital LLC	100,800	$0.50M	0.0%	N/A	0.476%
2/16/2021	Squarepoint Ops LLC	26,182	$0.13M	0.0%	+179.4%	0.124%
2/16/2021	Nuveen Asset Management LLC	34,257	$0.17M	0.0%	+20.5%	0.162%
2/16/2021	Price T Rowe Associates Inc. MD	29,874	$0.15M	0.0%	-90.2%	0.141%
2/16/2021	Gyon Technologies Capital Management LP	41,801	$0.21M	0.1%	N/A	0.197%
2/12/2021	Caas Capital Management LP	184,073	$0.91M	0.0%	N/A	0.869%
2/12/2021	Credit Suisse AG	33,976	$0.17M	0.0%	+201.3%	0.160%
2/11/2021	Northern Trust Corp	113,424	$0.56M	0.0%	-3.9%	0.535%
2/10/2021	Artisan Partners Limited Partnership	517,771	$2.55M	0.0%	+77.9%	2.444%
2/9/2021	Wells Fargo & Company MN	5,523	$27K	0.0%	-55.4%	0.026%
2/9/2021	Bank of New York Mellon Corp	30,336	$0.15M	0.0%	+6.4%	0.143%
2/5/2021	BlackRock Inc.	828,568	$4.08M	0.0%	+69.6%	3.911%
2/5/2021	SG Americas Securities LLC	23,210	$0.11M	0.0%	-24.3%	0.110%
1/22/2021	Candriam Luxembourg S.C.A.	362,346	$1.78M	0.0%	+54.9%	1.710%
1/21/2021	Hershey Trust Co.	9,822	$48K	0.0%	N/A	0.046%
11/16/2020	Cubist Systematic Strategies LLC	1,919	$46K	0.0%	N/A	0.009%
11/16/2020	Squarepoint Ops LLC	9,371	$0.23M	0.0%	N/A	0.044%
11/13/2020	Morgan Stanley	67,774	$1.63M	0.0%	-4.1%	0.320%
11/13/2020	Charles Schwab Investment Management Inc.	70,748	$1.70M	0.0%	+64.0%	0.334%
11/10/2020	State Street Corp	128,112	$3.08M	0.0%	+4.2%	0.605%
11/6/2020	BlackRock Inc.	488,488	$11.75M	0.0%	+1.9%	2.306%
11/5/2020	California Public Employees Retirement System	16,561	$0.40M	0.0%	+3.8%	0.078%
11/5/2020	Wells Fargo & Company MN	12,370	$0.30M	0.0%	+6.5%	0.058%

Data available starting January 2016

Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidate is the ATRN-119 that is in Phase I clinical trials for treating advanced solid tumors. The company is also developing ATRN-1051 for the treatment of ovarian cancer; and APRE-DDRi for the treatment of advanced solid tumors. The company is headquartered in Doylestown, Pennsylvania.

Today's Range

Now: $3.22

$3.15

$3.36

50 Day Range

MA: $3.41

$2.54

$4.45

52 Week Range

Now: $3.22

$2.15

$8.85

Volume

18,883 shs

Average Volume

20,359 shs

Market Capitalization

$17.50 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.88

Who are the company insiders with the largest holdings of Aprea Therapeutics?: Aprea Therapeutics' top insider shareholders include:
Oren Gilad (CEO)
Marc Duey (Director)
Bernd R Seizinger (Director)
John P Hamill (CFO)
Learn More about top insider investors at Aprea Therapeutics.